AptarGroup Inc

ATR: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
HyyLOCK|J>z<RLOCK|!Z%y$^

Aptar Earnings: Growth in Pharma Offset by Currency Effects and Declines in Beauty and Closures

Aptar reported 3% year-on-year declines in sales on a reported basis but flat sales on a constant currency basis. Expected declines in beauty and closures offset the 3% constant-currency growth in the pharma segment, which enjoyed strong growth in prescription core sales.

Sponsor Center